Eribulin mesylate

• Target:

  Apoptosis|||Microtubule Associated

• Related Pathways:

  Apoptosis|||Cytoskeletal Signaling

• Purity:

  >99.99%

• Bioactivity:

  Eribulin mesylate (E7389 mesylate) (E7389 mesylate) inhibits the proliferation of cancer cells by binding microtubule proteins and microtubules. Eribulin mesylate (E7389 mesylate) is a microtubule targeting agent that is used in the treatment of metastatic breast cancer.

• Smiles:

  CS(O)(=O)=O.[H][C@@]12CC(=C)[C@]([H])(CC[C@@]3([H])C[C@@H](C)C(=C)[C@@]([H])(C[C@]4([H])O[C@H](C[C@H](O)CN)[C@H](OC)[C@@]4([H])CC(=O)C[C@@]4([H])CC[C@]5([H])O[C@@]6([H])[C@@]7([H])O[C@@]8(C[C@@]7([H])O[C@@]6([H])[C@@]([H])(O8)[C@@]5([H])O4)CC1)O3)O2

• Molecular Formula:

  C41H63NO14S

• Molecular Weight:

  826

• Shipping Conditions:

  Cool pack

• Storage Temperature:

  -20°C

• CAS Number:

  441045-17-6